Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the Ladenburg Thalmann 2015 Healthcare

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that Paul Ziegler has been named Vice President of Sales, effective

Increases available net borrowing capacity to $30 million RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that it has

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the second quarter 2015.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release second quarter 2015 financial and operating results after the market closes on Thursday, August 6, 2015 . Todd M. Pope , President & Chief Executive Officer and Joseph P.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT: TRXC ), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that the underwriters of its previously announced public offering

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT: TRXC ), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the pricing of its underwritten public offering of 16,666,667

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT: TRXC ), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced it intends to offer shares of its common stock in an underwritten

-- First Patient-Side Robotically Enhanced Laparoscopic Surgery Platform -- RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT: TRXC ), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the first quarter 2015.